Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blau

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the Endocrine Society|September 16, 2022
Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin ReceptorsAkua Graf, James Welch, Rashika Bansal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 12, 2022
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated HypophosphatemiaIris R Hartley, Rachel I Gafni, Kelly L Roszko, et al.
Endocrine-Related Cancer|February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directivesC R C Pieterman, S M Sadowski, J E Maxwell, et al.
Diabetes/Metabolism Research and Reviews|March 10, 2024
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver diseaseFederica Tavaglione, Valentina Flagiello, Francesca Terracciani, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
The New England Journal of Medicine|November 17, 2021
Parathyroid Hormone Resistance and Autoantibodies to the PTH1 ReceptorAdel Mandl, Peter D Burbelo, Giovanni Di Pasquale, et al.
Journal of Hepatology|January 11, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trialsJavier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the Endocrine Society|September 16, 2022
Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin ReceptorsAkua Graf, James Welch, Rashika Bansal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 12, 2022
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated HypophosphatemiaIris R Hartley, Rachel I Gafni, Kelly L Roszko, et al.
Endocrine-Related Cancer|February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directivesC R C Pieterman, S M Sadowski, J E Maxwell, et al.
Diabetes/Metabolism Research and Reviews|March 10, 2024
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver diseaseFederica Tavaglione, Valentina Flagiello, Francesca Terracciani, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
The New England Journal of Medicine|November 17, 2021
Parathyroid Hormone Resistance and Autoantibodies to the PTH1 ReceptorAdel Mandl, Peter D Burbelo, Giovanni Di Pasquale, et al.
Journal of Hepatology|January 11, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trialsJavier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Pageof 7